A Long-Term View of Cardiovascular Risk After Cancer Treatment
Stephanie Dixon, MD, MPH
Reducing Cardiovascular Risk in Adult Survivors of Childhood Cancer
How Myeloid Mutations in ALL Inform Treatment Decisions
Caner Saygin, MD
Key Questions Shaping Chemotherapy-Free Treatment in Mantle Cell Lymphoma
Jonathon B. Cohen, MD, MS
Supportive Care Before CLL Treatment: Infection Risk and Comorbidity Management
Kerry A. Rogers, MD
Moving Beyond Chemotherapy in Mantle Cell Lymphoma Care
Jonathon Cohen, MD, MS
Adapting CV Risk Reduction Strategies for Cancer Survivorship
Myeloid Mutations in ALL: Disease Risk and Prognostic Implications
Making the Most of WCLC 2026: A Guide for Early-Career Professionals
Triparna Sen, PhD
Resistance and Transformation in EGFR-Mutant Lung Cancer
A Look at WCLC 2026: Pivotal Trials and Emerging Directions
Closing the Colonoscopy Follow-Up Gap: Insights from a JNCCN Study
Peter Buch, MD, FACG, AGAF, FACP
Mallik Greene, PhD
Jordan Karlitz, MD
Closing Gaps in CRC Screening: From Stool-Based Testing to Timely Colonoscopy
Shelina Ramnarine, PhD
David A. Johnson, MD, FACG, FACP
Redefining Endocrine Therapy: The Evidence Behind Oral SERDs and PROTAC ER Degraders
Komal Jhaveri, MD, FACP
Translating Safety Data Into Practice: Effective AE Management in Oral SERD and PROTAC Regimens
Virginia Kaklamani, MD, DSc
Is There a Role for Primary Tumor Surgery in Metastatic Breast Cancer?
Lajos Pusztai, MD, DPhil
Loading...
NEW FEATURES:
Tell us what you think by using the Feedback button on the right side of the page.
We're glad to see you're enjoying Global Oncology Academy… but how about a more personalized experience?
Press cancel to remain on Global Oncology Academy. Press the link below or the continue button to keep going.